BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/12/2024 3:55:58 PM | Browse: 120 | Download: 327
 |
Received |
|
2024-03-01 08:20 |
|
Peer-Review Started |
|
2024-03-01 08:20 |
|
First Decision by Editorial Office Director |
|
2024-04-17 03:17 |
|
Return for Revision |
|
2024-04-17 03:17 |
|
Revised |
|
2024-04-18 12:56 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-04-30 02:33 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-04-30 10:08 |
|
Articles in Press |
|
2024-04-30 10:08 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-06-19 09:34 |
|
Publish the Manuscript Online |
|
2024-07-12 15:55 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yusuf Ilhan and Yakup Ergun |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yakup Ergun, MD, Department of Medical Oncology, Antalya City Hospital, Gocerler neighborhood, 5379 Street, Antalya 07080, Türkiye. dr.yakupergun@gmail.com |
| Key Words |
Hepatocellular carcinoma; Transarterial chemoembolization; Transarterial radioembolization; Tyrosine kinase inhibitors; Immune checkpoint inhibitors |
| Core Tip |
Combining transarterial chemoembolization (TACE) with tyrosine kinase inhibitors and immune checkpoint inhibitors shows promise in enhancing therapeutic outcomes for hepatocellular carcinoma (HCC) patients, offering viable alternatives when TACE alone is ineffective or unsuitable. Further exploration and validation of these combination therapies with TACE, as well as investigating other local treatment options for potential synergistic effects, are warranted to optimize HCC treatment strategies. |
| Publish Date |
2024-07-12 15:55 |
| Citation |
Ilhan Y, Ergun Y. Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies. World J Gastrointest Oncol 2024; 16(7): 2888-2893 |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i7/2888.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i7.2888 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
